Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell-ness: a "magic marker" for cancer.

John P Lahad1, Gordon B Mills, Kevin R Coombes

  • 1Department of Molecular Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

The Journal of Clinical Investigation
|June 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers.

Science translational medicine·2017
Same author

Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017
Same author

Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.

Bioinformatics (Oxford, England)·2017
Same author

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

Cancer cell·2017
Same author

Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.

Cancer research·2017
Same author

Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human Cancer.

Cancer research·2017

Researchers identified an 11-gene signature linked to stem cell characteristics. This signature may predict patient prognosis across various cancers, potentially guiding personalized cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Transcriptional profiling of tumors offers personalized cancer therapy by identifying patients for specific treatments.
  • Translating this potential into tangible patient benefits has faced significant challenges.
  • Tumor stem cell-like characteristics are hypothesized to correlate with poor prognosis.

Discussion:

  • Glinsky and colleagues explored a stem cell mRNA signature in human and murine models.
  • An 11-gene expression signature associated with stem cell-ness was identified.
  • This signature demonstrated the ability to stratify patients with diverse cancers into distinct prognostic groups.

Key Insights:

  • The identified 11-gene signature shows promise in differentiating between good and poor prognosis in cancer patients.

Related Experiment Videos

  • This molecular marker could potentially serve as a predictive tool for treatment response and patient outcomes.
  • The findings suggest a link between stem cell-like properties and cancer aggressiveness.

    • Outlook:

    • Further validation of this "stem cell-ness" signature is crucial for clinical application.
    • If validated, this marker could significantly impact patient care and treatment decisions.
    • Challenges remain in the creation and robust validation of such predictive gene signatures.